This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Individual

Dr. Steven A. Rosenberg

cancer immunotherapy pioneer, doctor, researcher, Surgical Oncologist | Bethesda | MD | USA

Details

Roles / Typescancer immunotherapy pioneer, doctor, researcher, Surgical Oncologist

Websitehttps://www.cancer.gov/news-events/press-releases/2023/rosenberg-national-medal-of-technology-and-innovation

Summary

NCI surgical oncologist and immunotherapy pioneer known for interleukin-2, TIL therapy, adoptive cell transfer, and early CAR T-cell work. Steven A. Rosenberg, MD, PhD, is chief of the Surgery Branch at the National Cancer Institute Center for Cancer Research and one of the central figures in modern cancer immunotherapy.

Details

Steven A. Rosenberg, MD, PhD, is chief of the Surgery Branch at the National Cancer Institute Center for Cancer Research and one of the central figures in modern cancer immunotherapy. NCI describes him as a pioneer of interleukin-2 cancer immunotherapy, tumor-infiltrating lymphocyte therapy, adoptive cell transfer, human gene therapy, and genetically engineered immune-cell approaches for cancer.